In cell therapy, historical media production methods have typically utilized off-the-shelf, single-use assemblies from blood management suppliers with open connection devices. The use of these assemblies requires open processing in ISO 5 biological safety cabinets (BSCs), with significant manual labor required to aseptically access and transfer media components. Manual and open media production processes create capacity challenges that are only partially alleviated with efficiency improvements to the manual methods. Furthermore, these methods also create potential contamination risks. An automated media production system has been developed to dispense individual components, mix the components, and fill the compounded media into a large ...
The current autologous chimeric antigen receptor (CAR)-T cell therapy products, both commercially ap...
Ex vivo genetically-modified cellular immunotherapies, such as chimeric antigen receptor T-cells (CA...
A scalable biomanufacturing platform is crucial to meet the anticipated demands for off-the-shelf ce...
Many of the standard cell culturing unit operations utilized by early stage CAR-T manufacturing proc...
CAR-T Cell Therapy manufacturing processes require handling of small volume process and product comp...
As supporting processes, culture media and buffer preparation add little direct value to the biophar...
Introduction: Current production facilities for Cell-Based Health care Products (CBHPs), also referr...
Autologous cell therapies are currently being evaluated in multiple clinical trials and are becoming...
The benefits of single-use systems (SUS) in biopharmaceutical manufacturing are well understood, and...
The manufacturing of cell therapy is a complex sequence of different unit operations. The substantia...
The fast-growing biopharmaceutical industry demands speedy development of highly efficient and relia...
In response to increased demands placed on biopharmaceutical manufacturers to diversify portfolios a...
Advanced Therapy Medicinal Products (ATMP) provide promising treatment options particularly for unme...
Ex vivo genetically-modified cellular immunotherapies, such as chimeric antigen receptor T-cells (CA...
The rapidly growing field of cell therapy is providing very promising treatments for conditions that...
The current autologous chimeric antigen receptor (CAR)-T cell therapy products, both commercially ap...
Ex vivo genetically-modified cellular immunotherapies, such as chimeric antigen receptor T-cells (CA...
A scalable biomanufacturing platform is crucial to meet the anticipated demands for off-the-shelf ce...
Many of the standard cell culturing unit operations utilized by early stage CAR-T manufacturing proc...
CAR-T Cell Therapy manufacturing processes require handling of small volume process and product comp...
As supporting processes, culture media and buffer preparation add little direct value to the biophar...
Introduction: Current production facilities for Cell-Based Health care Products (CBHPs), also referr...
Autologous cell therapies are currently being evaluated in multiple clinical trials and are becoming...
The benefits of single-use systems (SUS) in biopharmaceutical manufacturing are well understood, and...
The manufacturing of cell therapy is a complex sequence of different unit operations. The substantia...
The fast-growing biopharmaceutical industry demands speedy development of highly efficient and relia...
In response to increased demands placed on biopharmaceutical manufacturers to diversify portfolios a...
Advanced Therapy Medicinal Products (ATMP) provide promising treatment options particularly for unme...
Ex vivo genetically-modified cellular immunotherapies, such as chimeric antigen receptor T-cells (CA...
The rapidly growing field of cell therapy is providing very promising treatments for conditions that...
The current autologous chimeric antigen receptor (CAR)-T cell therapy products, both commercially ap...
Ex vivo genetically-modified cellular immunotherapies, such as chimeric antigen receptor T-cells (CA...
A scalable biomanufacturing platform is crucial to meet the anticipated demands for off-the-shelf ce...